Company Filing History:
Years Active: 2002
Title: Jay B. Lichter: Innovator in Genetic Research
Introduction
Jay B. Lichter is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of genetic research, particularly in understanding drug metabolism through genetic polymorphisms.
Latest Patents
Lichter holds a patent for "Isolated CYP3A4 nucleic acid molecules and detection methods." This invention identifies genetic variations in the human CYP3A4 gene that can alter drug metabolism. The nucleic acids containing these polymorphic sequences are utilized to screen patients for variations in metabolism related to CYP3A4 substrates. This screening can help identify potential drug-drug interactions, adverse effects, and diseases linked to environmental or occupational toxin exposure. Furthermore, these nucleic acids are instrumental in establishing animal, cell, and in vitro models for studying drug metabolism.
Career Highlights
Jay B. Lichter is associated with Dna Sciences Laboratories, Inc., where he continues to advance research in genetic polymorphisms and their implications in pharmacology. His work has paved the way for better patient care through personalized medicine.
Collaborations
Lichter collaborates with Marco Guida, contributing to innovative research and development in the field of genetics.
Conclusion
Jay B. Lichter's work exemplifies the intersection of genetics and pharmacology, showcasing the importance of understanding genetic variations in drug metabolism. His contributions are vital for advancing personalized medicine and improving patient outcomes.